HomeInsightsStock Comparison

Aarti Pharmalabs Ltd vs Acutaas Chemicals Ltd Stock Comparison

Aarti Pharmalabs Ltd vs Acutaas Chemicals Ltd Stock Comparison

Last Updated on: Jun 18, 2025

Key Highlights

  • The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 879.7 as of 18 Jun 15:30.
  • The P/E Ratio of Aarti Pharmalabs Ltd changed from 12.9 on March 2023 to 18.2 on March 2024 . This represents a CAGR of 18.78% over 2 yearsThe P/E Ratio of Ami Organics Ltd changed from 50.6 on March 2022 to 94.3 on March 2024 . This represents a CAGR of 23.06% over 3 years.
  • The Market Cap of Aarti Pharmalabs Ltd changed from ₹ 2489 crore on March 2023 to ₹ 3942 crore on March 2024 . This represents a CAGR of 25.85% over 2 yearsThe Market Cap of Ami Organics Ltd changed from ₹ 3642 crore on March 2022 to ₹ 4036 crore on March 2024 . This represents a CAGR of 3.48% over 3 years.
  • The revenue of Aarti Pharmalabs Ltd for the Mar '25 is ₹ 562.17 crore as compare to the Dec '24 revenue of ₹ 542.81 crore. This represent the growth of 3.57% The revenue of Ami Organics Ltd for the Mar '25 is ₹ 314.26 crore as compare to the Dec '24 revenue of ₹ 276.66 crore. This represent the growth of 13.59%.
  • The ebitda of Aarti Pharmalabs Ltd for the Mar '25 is ₹ 144.02 crore as compare to the Dec '24 ebitda of ₹ 133.64 crore. This represent the growth of 7.77% The ebitda of Ami Organics Ltd for the Mar '25 is ₹ 90.74 crore as compare to the Dec '24 ebitda of ₹ 70.34 crore. This represent the growth of 29%.
  • The net profit of Aarti Pharmalabs Ltd changed from ₹ 47.09 crore to ₹ 88.34 crore over 8 quarters. This represents a CAGR of 36.97% The net profit of Ami Organics Ltd changed from ₹ 22.24 crore to ₹ 62.72 crore over 8 quarters. This represents a CAGR of 67.93% .
  • The Dividend Payout of Aarti Pharmalabs Ltd changed from 10.55 % on March 2023 to 13.55 % on March 2024 . This represents a CAGR of 13.33% over 2 yearsThe Dividend Payout of Ami Organics Ltd changed from 15.19 % on March 2022 to 25.33 % on March 2024 . This represents a CAGR of 18.58% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aarti Pharmalabs Ltd

  • Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019.
  • The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.
  • It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021.

About Ami Organics Ltd

  • Ami Organics Limited was initially formed as a partnership firm in the name of 'Ami Organics' with effect from 03 January, 2004 at Surat, India.
  • The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007.
  • Subsequently, the Company was converted into a Public Limited Company, following which the Company's name was changed to 'Ami Organics Limited', and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018. The Company is engaged in business of drugs intermediate chemicals and related activities.
  • The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015.

Aarti Pharmalabs Ltd News Hub

News

Board of Aarti Pharmalabs recommends final dividend

Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held ...

Read more

12 May 2025 09:19

News

Aarti Pharmalabs Q4 PAT climbs 35% YoY to Rs 88 cr

Revenue from operations jumped 11.46% YoY to Rs 563.78 crore in the quarter ended 31 March...

Read more

12 May 2025 10:44

News

Aarti Pharmalabs to conduct board meeting

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 10 May 20...

Read more

25 Apr 2025 11:27

News

Aarti Pharmalabs achieves SBTi approval for its emission reduction goals

Aarti Pharmalabs announced that its ambitious Science Based Targets (SBTs) for emissions h...

Read more

16 Apr 2025 16:40

News

Aarti Pharmalabs spurts after Q3 PAT climbs 40% YoY to Rs 74 cr

Revenue from operations grew 19.9% to Rs 537.78 crore in the quarter ended 31 December 202...

Read more

06 Feb 2025 11:08

News

Board of Aarti Pharmalabs recommends interim dividend

Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held ...

Read more

05 Feb 2025 20:52

Ami Organics Ltd News Hub

News

Board of AMI Organics recommends final dividend

AMI Organics announced that the Board of Directors of the Company at its meeting held on 2...

Read more

02 May 2025 14:08

News

Ami Organics jumps after Q4 PAT soars to Rs 627 cr

Revenue from operations jumped 37.13% year on year to Rs 308.48 crore during the quarter e...

Read more

02 May 2025 14:49

News

AMI Organics to hold board meeting

AMI Organics will hold a meeting of the Board of Directors of the Company on 2 May 2025. P...

Read more

25 Apr 2025 11:18

News

Ami Organics' Unit II receives Japan PMDA nod for GMP compliance

Ami Organics' manufacturing facility, Unit II situated at Ankleshwar, which is involved in...

Read more

24 Apr 2025 15:57

News

AMI Organics to hold EGM

AMI Organics announced that an Extra Ordinary General Meeting (EGM) of the Company will be...

Read more

16 Apr 2025 20:44

News

Board of Ami Organics approves change in company name to Acutaas Chemicals

The Board of Ami Organics at its meeting held on 16 April 2025 has approved the change in ...

Read more

16 Apr 2025 15:03

SWOT Analysis Of Ami Organics Ltd

Strength

5

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Aarti Pharmalabs Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ami Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aarti Pharmalabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aarti Pharmalabs Ltd and Ami Organics Ltd

Which company has a larger market capitalization, Aarti Pharmalabs Ltd or Ami Organics Ltd?

Market cap of Aarti Pharmalabs Ltd is 7,973 Cr while Market cap of Ami Organics Ltd is 9,061 Cr

What are the key factors driving the stock performance of Aarti Pharmalabs Ltd and Ami Organics Ltd?

The stock performance of Aarti Pharmalabs Ltd and Ami Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Pharmalabs Ltd and Ami Organics Ltd?

As of June 18, 2025, the Aarti Pharmalabs Ltd stock price is INR ₹879.7. On the other hand, Ami Organics Ltd stock price is INR ₹1106.8.

How do dividend payouts of Aarti Pharmalabs Ltd and Ami Organics Ltd compare?

To compare the dividend payouts of Aarti Pharmalabs Ltd and Ami Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions